# OnCo record jaffer-ajani (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jaffer-ajani/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jaffer-ajani" ;
  schema:name "Jaffer A. Ajani"@en ;
  schema:description "Gastro-oesophageal oncologist who co-led CheckMate 649, the trial that added nivolumab to first-line gastric cancer chemotherapy."@en ;
  schema:url <https://onco.cc/people/jaffer-ajani/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Ajani%20JA%5BAuthor%5D%20gastric%20nivolumab> ;
  onco:tag "gastric", "esophageal", "immunotherapy" ;
  schema:jobTitle "Professor of Gastrointestinal Medical Oncology, MD Anderson Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0001-9946-0629> ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/esophageal/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/checkmate-649/>, <https://onco.cc/trials/checkmate-648/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-649-lancet-2021/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .
